Prolactin Modulates the Incidence of Diabetes in Male and Female Nod Mice

References

• Frantz AG. Prolactin. N. E. J. Med. 1978; 298: 201–207
   PubMed Web of Science ®Google Scholar
• Gala RR. Prolactin and Growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 1991; 198: 513–527
   PubMed Web of Science ®Google Scholar
• Berczi I. The role of prolactin in the pathogenesis of autoimmune disease. Endocr Pathol 1993; 4: 178–195
   PubMedGoogle Scholar
• Skwarlo-Sonta K. Prolactin as an immunoregulatory hormone in mammals and birds. Immunol. Lett. 1992; 33: 105–121
   PubMed Web of Science ®Google Scholar
• Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magnum BE. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosprine. J. Immunol. 1985; 134: 3027–3031
   PubMedGoogle Scholar
• Gagnerault MC, Touraine P, Savino W, Kelly PA, Dar-Denne M. Expression of prolactin receptors in murine lymphiod cells in normal and autoimmune situations. J. Immunol. 1993; 150: 5673–5681
   PubMedGoogle Scholar
• Gala RR, Shevach EM. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 1993; 133: 1617–1623
   PubMedGoogle Scholar
• Viselli SM, Mastro AM. Prolactin receptors are found on heterogeneous subpopulations of rat splenocytes. Endocrinology 1993; 132: 571–576
   PubMedGoogle Scholar
• Nagy E, Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinol. 1978; 89: 530–537
   PubMedGoogle Scholar
• Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 1983; 102: 351–357
   PubMedGoogle Scholar
• Hartmann DP, Holaway JW, Bernton EW. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 1989; 3: 2194–2202
   PubMed Web of Science ®Google Scholar
• De Pozo E, Fliickiger E. Pharmocological aspects of the prolactin inhibitor bromocriptine. Clinical Neuroendocrinology: A Pathophysiological Approach, G. Tolis. Raven press, NY 1979; 429–435
   Google Scholar
• Vance ML, Evans WS, Thorner MO. Bromocriptine. Ann. Int. Med. 1984; 100: 78–91
   PubMed Web of Science ®Google Scholar
• Nagy E, Berczi I, Wren GE, Asa SH, Kovacs K. Immuno-modulation by bromocriptine. Immunopharmacology 1983; 6: 231–243
   PubMed Web of Science ®Google Scholar
• Bach JF. Mechanisms of autoimminity in IDDM. Clin Exp. Immunol. 1988; 72: 1–8
   PubMed Web of Science ®Google Scholar
• Gepts W. Pathology and anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Doniach DG, Bottazzo GF, Cudworth AG. Etiology of type I diabetes mellitus heterogeniety and immunological events leading to clincial onset. Ann. Rev. Med. 1983; 34: 13–20
   PubMedGoogle Scholar
• Kikutani H, Makino S. The mouse autoimmune diabetes model: NOD and related strains. Adv. Immunol. 1992; 51: 285–311
   PubMed Web of Science ®Google Scholar
• Makino S, Kunimoto K, Muraoka Y, Katagiri K. Effects of castration on the appearance of diabetes in NOD mice. Exp. Animal. 1981; 3: 137–140
   Google Scholar
• Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration alone or combined with thymectomy, on the development of diabetes in the non-obese diabetic mouse. Endocrinology 1991; 129: 1382–1390
   PubMed Web of Science ®Google Scholar
• Hawkins TA, Gala RR, Dunbar JC. The effect of neonatal sex hormone manipulation on the incidence of diabetes in NOD mice. Proc. Soc. Exp. Biol. Med. 1993; 202: 201–205
   PubMed Web of Science ®Google Scholar
• de Greef WJ, Zeilmaker GH. Regulation of prolactin during the luteal phase in the rat. Endocrinology 1978; 102: 1190–1198
   PubMedGoogle Scholar
• Adler RA. The anterior pituitary grafted rat: A valid model for chronic hyperprolactinemia. Endocr. Rev. 1986; 7: 302–313
   PubMed Web of Science ®Google Scholar
• McMurray R, Keisler D, Kankel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 1991; 47: 3780–3787
   Google Scholar
• Gala RR, Shevach EM. Evidence for the release of a prolactin-like substance by mouse lymphocytes and macrophages. Proc. Soc. Exp Biol. Med. 1994; 205: 12–19
   PubMedGoogle Scholar
• Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb2 rat lymphomas. Cancer Res. 1980; 40: 2433–2436
   PubMedGoogle Scholar
• Pozzilli P, Signore A, Williams AJK, Beales PE. NOD mouse colonies around the world; recent facts and figures. Immunol. Today. 1993; 14: 193–196
   PubMedGoogle Scholar
• Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune response and autoimmune disease. Am. J. Pathol. 1985; 121: 531–551
   PubMed Web of Science ®Google Scholar
• Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response; fact and hypothesis. J. Steriod Biochem. 1989; 34: 241–251
   Google Scholar
• Telford N, Sinha YN, Finch CE. Hormonal influences on the E2-induced age-related increases of pituitary dopamine in C57BL/6J mice. Neuroendocrinology. 1987; 46: 481–487
   PubMedGoogle Scholar
• Brelje TC, Parsons JA, Sorenson RL. Regulation of islet p-cell proliferation by prolactin in rat islets. Diabetes. 1994; 43: 263–273
   PubMedGoogle Scholar
• Houssay BA, Anderson E, Bates RW, Li CH. Diabetogenic actions of prolactin. Endocrinology 1955; 57: 55–63
   PubMedGoogle Scholar
• Lavalle C, Loyo E, Paniagua R, Bermodez JA, Herrerra A, Gonzalez-Barcena D. Correlation study between prolactin and androgens in male patients. J. Rheumat. 1987; 14: 268–272
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog. Neurobiol. 1989; 33: 399–447
   PubMed Web of Science ®Google Scholar
• Villanua MA, Szary A, Bartke A, Esquifino A. Changes in lymphoid organs of Ames dwarf mice after treatment with growth hormone, prolactin or ectopic pituitary transplants. J. Endocrinol. Invest. 1992; 15: 587–595
   PubMedGoogle Scholar